Celgene Corp. buy tamam
Start price
24.08.15
/
50%
€102.94
Target price
28.08.15
€117.40
Performance (%)
7.65%
End price
28.08.15
€110.81
Summary
This prediction ended on 28.08.15 with a price of €110.81. The BUY prediction by tamam finished with a performance of 7.65%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by tamam for this prediction
In the thread Celgene Corp. diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 24.08.2015 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 130.16€ zu.
(Vom Mitglied beendet)